ARCHIVES

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP Last Month

March 25, 2011

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014

H. Lee Moffitt Center Reads The Cancer Letter

July 19, 2002

Appropriators Ask What Happens After NIH Budget-Doubling Ends In FY2004.

May 25, 2001

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official

June 27, 1980